Skip to content

Efficacy of Patients own Platelet Rich Plasma in Caesarean wound healing

Efficacy of Prophylactic Autologous Platelet Rich Plasma in Caesarean wound healing - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054866
Enrollment
44
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O997- Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Platelet rich plasma: Autologous platelet rich plasma instillation in caesarean wound during caesarean section before skin closure. Patient will be observed till 42 days postoperatively

Sponsors

University College of Medical Sciences and Guru Teg Bahadur Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant woman of more than 28 week period of gestation of any age and parity undergoing caesarean delivery between 9 am to 4 pm. 2. Willingness to follow up in UCMS & GTB Hospital

Exclusion criteria

Exclusion criteria: 1. Anaemia (Hb 2. Thrombocytopenia 3. Patients with Hep B, Hep C, HIV, Syphilis 4. Patients with any dermatological condition around the surgical site 5. Febrile Patients

Design outcomes

Primary

MeasureTime frame
Comparison of wound healing by Mean REEDA (Redness Ecchymosis Edema Ecchymosis Discharge Approximation) score in both groupsTimepoint: - day 3 - day 8 (Primary Caesarean) or 10 (Repeat Caesarean) - day 42

Secondary

MeasureTime frame
- Total number of superficial & deep surgical site infection in both groups - Comparison of length of hospital stay due to wound related complications in both groups - Determine the organisms associated with caesarean surgical site infection in both groupsTimepoint: - day 3 - day 8 (Primary Caesarean) or 10 (Repeat Caesarean) - day 42

Countries

India

Contacts

Public ContactMITALI

UCMS and GTB Hospital

gautamdrricha1@gmail.com7011484180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026